Irum Khan

University of Illinois System

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (5)

Carlos Camacho

Associate Professor

University of Pittsburgh

UNITED STATES

View details

Rick Oerlemans

University of Groningen

NETHERLANDS

View details

Rebeca Rodríguez-Veiga

Instituto de Investigación Sanitaria La Fe

SPAIN

View details

john quigley

Professor of Medicine

University of Chicago

UNITED STATES

View details

Jeffrey Tyner

Assistant Professor

Oregon Health & Science University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Irum Khan

Research Interests

Explore related searches

Contact this professor

Articles (10)

Favorable outcomes of NPM1mut AML patients are due to transcriptional inactivation of FOXM1, presenting a new target to overcome chemoresistance

The antagonistic duality of NPM1 mutations in AML

FOXM1-AKT Positive Regulation Loop Provides Venetoclax Resistance in AML.

Novel FOXM1 inhibitor identified via gene network analysis induces autophagic FOXM1 degradation to overcome chemoresistance of human cancer cells.

Impact of race on outcomes in intermediate-risk acute myeloid leukemia

Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia.

Extended treatment response to imatinib in Rosai-Dorfman disease.

Therapeutic Vulnerabilities of Transcription Factors in AML

A multi-institutional comparison of mitoxantrone, etoposide, and cytarabine vs high-dose cytarabine and mitoxantrone therapy for patients with relapsed or refractory acute myeloid leukemia.

Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short- and long-term clinical outcomes: a large, retrospective, multicenter, international study.

Collaborators (5)

Carlos Camacho

Rick Oerlemans

Rebeca Rodríguez-Veiga

john quigley

Jeffrey Tyner

Make your next move.